Brief: DBP International Q4 Operating Loss Narrows To SEK 1.4 Mln
21/02/2020 06:58
Feb 21 (Reuters) - Double Bond Pharmaceutical International
AB DBPHAb.TE :
* Q4 TOTAL REVENUES SEK 2.9 MLN VS SEK 0.8 MLN YEAR AGO
* Q4 OPERATING LOSS SEK 1.4 MLN VS LOSS SEK 2.2 MLN YEAR AGO
Source text for Eikon: urn:newsml:reuters.com:*:nWkr544xbX
Further company coverage: DBPHAb.TE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10))
Recent news on Double Bond Pharmaceutical International AB (publ)
See all newsBrief: DBP International AB And Vivo Biopharma LLC Revised Asset Purchase And Collaboration Agreements
Brief: DBP International AB And Vivo Biopharma LLC Enter Into Asset Purchase And Collaboration Agreements To Develop And Commercialize A Novel Glioblastoma Treatment
Brief: DBP And Vivo Enter Into Asset Purchase And Collaboration Agreements To Develop And Commercialize A Novel Glioblastoma Treatment
Brief: Double Bond Pharmaceutical Says Positive Response For SI-053 From Ethical Committee In Netherlands Has Been Received
Brief: Double Bond To Cooperate With Belarus State Medical University